4//SEC Filing
TETRAPHASE PHARMACEUTICALS INC 4
Accession 0001209191-14-005447
CIK 0001373707operating
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 12:13 PM ET
Size
7.0 KB
Accession
0001209191-14-005447
Insider Transaction Report
Form 4
Sutcliffe Joyce A.
Senior Vice President, Biology
Transactions
- Exercise/Conversion
Common Stock
2014-01-17$0.87/sh+51,724$45,000→ 51,724 total - Exercise/Conversion
Employee Stock Option (right to buy)
2014-01-17+51,724→ 0 totalExercise: $0.87Exp: 2023-09-11→ Common Stock (51,724 underlying)
Footnotes (1)
- [F1]The options vested as to 25% of the shares on September 11, 2010 and as to an additional 1/16 of the shares quarterly thereafter.
Documents
Issuer
TETRAPHASE PHARMACEUTICALS INC
CIK 0001373707
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001373707
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 12:13 PM ET
- Size
- 7.0 KB